Literature DB >> 989260

Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies.

W Szmuness, J H Hoofnagle, C E Stevens, A M Prince.   

Abstract

Four random samples representing populations at low (volunteer blood donors), intermediate, (VD clinic patients), high (family contacts of chronic antigen carriers) and very high (male homosexuals) risk of exposure to HBV were surveyed. Among HBsAg and anti-HBs negative individuals an average of 3.3% were found to be anti-HBc positive, and among those with anti-HBs, 19.4% were anti-HBc positive. Anti-HBc, with concurrent anti-HBs and without, was detected more frequently in the high risk samples than in the low risk. Individuals was a past history of acute viral hepatitis were more frequently anti-HBc positive than those without such a history, and anti-HBc positivity was frequently accompanied by serum transaminase elevation. Anti-HBc may persist for many years after an episode of acute hepatitis. In households of carriers, the highest frequency of anti-HBc was observed among spouses, which would argue for the possibility of sexual transmission. A significant excess of females with both types of antibody was observed in families of carriers. Anti-HBc determinations in conjunction with other HBV markers, provide a useful new tool for epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 989260     DOI: 10.1093/oxfordjournals.aje.a112298

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay.

Authors:  A M Spronk; L Schmidt; C Krenc; L Pavlis-Jenkins; J Brady; S Taskar; L Angus-Finn; L Mimms
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  IgM antibody to hepatitis B core antigen (anti-HBc IgM) in "healthy" HBsAg carriers: a longitudinal study of 75 cases.

Authors:  H H Dromeyer; W Arnold; P Kryger; J O Nielsen; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15

3.  Specialty conference: Chronic hepatitis B.

Authors: 
Journal:  West J Med       Date:  1978-04

4.  Hepatitis B core antigen synthesised in Escherichia coli: its use for antibody screening in patients attending a clinic for sexually transmitted diseases.

Authors:  B J Cohen; P A Litton; P P Mortimer; P Simmons
Journal:  J Hyg (Lond)       Date:  1984-10

5.  Epidemiological aspects of hepatitis B in Palermo: changes in HBV spread.

Authors:  V Intonazzo; G La Rosa; M F Massenti; A M Perna; E Restivo; A Sferlazzo; L Dardanoni
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

6.  [Anti-HBc IgM in acute and chronic hepatitis B virus infection].

Authors:  K Gmelin; L Theilmann; G Hasche; H Will; P Czygan; H W Doerr; B Kommerell
Journal:  Klin Wochenschr       Date:  1984-09-03

7.  Hepatitis B serology in Greek prostitutes: significance of the different serum markers.

Authors:  E Kaklamani; A Kyriakidou; D Trichopoulos; G Papoutsakis; I Koumandaki; D Karalis
Journal:  J Hyg (Lond)       Date:  1980-04

8.  Impact of technological developments on infectious disease epidemiology: Lessons from the first 100 years of AJE.

Authors:  Betsy Foxman; Shruti Mehta
Journal:  Am J Epidemiol       Date:  2022-03-31       Impact factor: 5.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.